The dual RAF/MEK inhibitor CH5126766/RO5126766 may be a potential therapy for RAS-mutated tumor cells.
about
Treatment of NRAS-mutated advanced or metastatic melanoma: rationale, current trials and evidence to dateTargeting mutant NRAS signaling pathways in melanoma.Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic TargetsSearching for the Chokehold of NRAS Mutant Melanoma.Targeting RAS-mutant cancers: is ERK the key?Blockage of the mevalonate pathway overcomes the apoptotic resistance to MEK inhibitors with suppressing the activation of Akt in cancer cells.
P2860
The dual RAF/MEK inhibitor CH5126766/RO5126766 may be a potential therapy for RAS-mutated tumor cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The dual RAF/MEK inhibitor CH5 ...... y for RAS-mutated tumor cells.
@ast
The dual RAF/MEK inhibitor CH5 ...... y for RAS-mutated tumor cells.
@en
The dual RAF/MEK inhibitor CH5 ...... y for RAS-mutated tumor cells.
@nl
type
label
The dual RAF/MEK inhibitor CH5 ...... y for RAS-mutated tumor cells.
@ast
The dual RAF/MEK inhibitor CH5 ...... y for RAS-mutated tumor cells.
@en
The dual RAF/MEK inhibitor CH5 ...... y for RAS-mutated tumor cells.
@nl
prefLabel
The dual RAF/MEK inhibitor CH5 ...... y for RAS-mutated tumor cells.
@ast
The dual RAF/MEK inhibitor CH5 ...... y for RAS-mutated tumor cells.
@en
The dual RAF/MEK inhibitor CH5 ...... y for RAS-mutated tumor cells.
@nl
P2093
P2860
P1433
P1476
The dual RAF/MEK inhibitor CH5 ...... y for RAS-mutated tumor cells.
@en
P2093
Mano Horinaka
Norito Katoh
Toshikazu Yamazaki
Toshiyuki Sakai
P2860
P304
P356
10.1371/JOURNAL.PONE.0113217
P407
P50
P577
2014-11-25T00:00:00Z